Ferah Oya, Akbulut Akın, Açık Mehmet Eren, Gökkaya Zafer, Acar Umut, Yenidünya Özlem, Yentür Ercüment, Tokat Yaman
Department of Anesthesiology and Reanimation, Surgical Intensive Care Unit, Şişli Florence Nightingale Hospital, Istanbul Bilim University, Istanbul, Turkey.
Department of Anesthesiology, Koç University Hospital, Istanbul, Turkey.
Transplant Proc. 2019 Sep;51(7):2430-2433. doi: 10.1016/j.transproceed.2019.01.174. Epub 2019 Jul 4.
The aim of this study is to investigate the effects of risk scores (Pediatric End-stage Liver Disease [PELD], Child-Turcotte-Pugh [CTP], and Pediatric Risk of Mortality [PRISM-III]) of pediatric liver transplant patients on the postoperative period.
Seven cadaveric and 45 living donors, totaling 52 pediatric liver transplantation (LT) patients, were reviewed retrospectively. PELD and CTP scores were calculated based on data at hospital admission. PRISM-III score was calculated from data during the first 24 hours of intensive care unit (ICU) admission. Hospital length of stay (LOS), ICU LOS, patients who developed acute kidney injury (AKI), requirement for inotropic-vasopressor therapy, hospital mortality, long-term mortality, duration of mechanical ventilation, metabolic disease, and demographic features were documented.For CTP score, class C was defined as high, and A and B as low. Cutoff values of PELD and PRISM-III scores were detected by using receiver operating characteristic curves. According to these cutoff values, patients were divided into 2 groups as high and low for each score. Documented data was analyzed and compared in groups for each score.
Hospital LOS was significantly longer in the high-PELD (P = .01) and high-CTP (P = .01) groups. ICU LOS was significantly longer in the high-PRISM-III group (P = .01). Requirement for inotropic-vasopressor therapy was significantly higher in the high-PELD (P = .04) and high-CTP (P = .04) groups.
Hemodynamic instability and long hospital LOS can be expected in pediatric post-LT patients with high PELD or CTP scores; there is also the risk that AKI maybe higher for high-PELD score patients. Unexpectedly, the PRISM-III score did not have any correlation with the severity of physiological condition and mortality.
本研究旨在调查小儿肝移植患者的风险评分(小儿终末期肝病[PELD]、Child-Turcotte-Pugh[CTP]和小儿死亡风险[PRISM-III])对术后阶段的影响。
回顾性分析了7例尸体供体和45例活体供体的52例小儿肝移植(LT)患者。根据入院时的数据计算PELD和CTP评分。PRISM-III评分根据重症监护病房(ICU)入院后前24小时的数据计算。记录住院时间(LOS)、ICU住院时间、发生急性肾损伤(AKI)的患者、使用血管活性药物治疗的需求、医院死亡率、长期死亡率、机械通气时间、代谢性疾病和人口统计学特征。对于CTP评分,C级定义为高,A和B级定义为低。通过使用受试者工作特征曲线检测PELD和PRISM-III评分的临界值。根据这些临界值,将患者按每个评分分为高分组和低分组。对每个评分的分组记录数据进行分析和比较。
高PELD组(P = 0.01)和高CTP组(P = 0.01)的住院时间显著延长。高PRISM-III组的ICU住院时间显著延长(P = 0.01)。高PELD组(P = 0.04)和高CTP组(P = 0.04)使用血管活性药物治疗的需求显著更高。
PELD或CTP评分高的小儿肝移植术后患者可能会出现血流动力学不稳定和较长的住院时间;高PELD评分患者发生AKI的风险也可能更高。出乎意料的是,PRISM-III评分与生理状况的严重程度和死亡率没有任何相关性。